Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

PD-L1 Gene Alterations Identify a Unique Subset of Diffuse Large B Cell Lymphoma That Harbors a T Cell Inflamed Phenotype

Justin Kline, MD, James Godfrey, MD, Sravya Tumuluru, Girish Venkataraman, MD MBBS, Robert J Orlowski, MD, Sonali M. Smith, MD, Riyue Bao, PhD

Blood (2018) 132 (Supplement 1): 673.

https://doi.org/10.1182/blood-2018-99-117189

Published: 2018

Journal Articles

Effect of Continuous Lenalidomide Treatment on Copy Number Alteration and Cytogenetic Abnormalities in Multiple Myeloma Cells

Paola Storti, PhD, Marina Bolzoni, PhD, Francesca Novara, PhD, Giannalisa Todaro, PhD, Valentina Marchica, Federica Costa, PhD, Tania Maldacena, PhD, Laura Notarfranchi, MD, Fabrizio Accardi, MD, Orsetta Zuffardi, PhD, Franco Aversa, MD, Nicola Giuliani, MD PhD, Gabriella Sammarelli, PhD

Blood (2017) 130 (Supplement 1): 3039.

https://doi.org/10.1182/blood.V130.Suppl_1.3039.3039

Published: 2017

Journal Articles

Age-Related Chromosomal Aberrations in Patients with Diffuse Large B-Cell Lymphoma

Eric Vick, PhD, Kruti Patel, DO, Noah Richardson, BA, Taylor Alloway, MD, Glenda M Delgado Ramos, MD, Alaa Altahan, MD, Michael G. Martin, MD

Blood (2017) 130 (Supplement 1): 1571.

https://doi.org/10.1182/blood.V130.Suppl_1.1571.1571

Published: 2017

Journal Articles

A Lysa Phase II Study of Oral JAK1/2 Inhibitor Ruxolitinib in Advanced Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL)

Eric W Van Den Neste, MD PhD, Marc Andre, MD, Thomas Gastinne, MD, Aspasia Stamatoullas, MD, Corinne Haioun, MD PhD, Amine Belhabri, MD, Oumedaly Reman, MD, Olivier Casasnovas, MD, Herve Ghesquieres, MD PhD, Gregor Verhoef, MD PhD, Marie-José Claessen, Hélène A Poirel, Marie-Christine Copin, Romain Dubois, Peter Vandenberghe, MD PhD, Ioanna-Andrea Stoian, Anne Ségolène Cottereau, MD, Laurent Knoops, MD PhD, Franck Morschhauser

Blood (2016) 128 (22): 4160.

https://doi.org/10.1182/blood.V128.22.4160.4160

Published: 2016

Journal Articles

Chromosome 9p24.1/ PD-L1 / PD-L2 Alterations and PD-L1 Expression and Treatment Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Nivolumab (PD-1 Blockade)

Blood (2016) 128 (22): 2923.

https://doi.org/10.1182/blood.V128.22.2923.2923

Published: 2016

Journal Articles

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Margaretha GM Roemer, MS, Ranjana H Advani, MD, Azra H. Ligon, PhD, Yasodha Natkunam, MD PhD, Robert A Redd, MS, Heather Homer, Courtney Connelly, Heather H. Sun, Sarah E. Daadi, Bjoern Chapuy, MD PhD, Daphne de Jong, MD PhD, Richard T. Hoppe, MD, Donna S Neuberg, ScD, Scott J Rodig, MD PhD, Margaret A. Shipp, MD

Blood (2015) 126 (23): 176.

https://doi.org/10.1182/blood.V126.23.176.176

Published: 2015

Journal Articles

Concurrent BCL2 / MYC Gene Amplification Associates with Increased DNA G-Quadruplex Formation in DLBCL

Samantha L. Kendrick, PhD, David Tannahill, PhD, Shankar Balasubramanian, PhD, Lisa M. Rimsza, MD

Blood (2015) 126 (23): 2641.

https://doi.org/10.1182/blood.V126.23.2641.2641

Published: 2015

Journal Articles

Nivolumab in Patients with Relapsed or Refractory Hodgkin Lymphoma - Preliminary Safety, Efficacy and Biomarker Results of a Phase I Study

Philippe Armand, MD PhD, Stephen M. Ansell, MD PhD, Alexander M. Lesokhin, MD, Ahmad Halwani, MD, Michael M. Millenson, MD, Stephen J. Schuster, MD, John Timmerman, MD, Ivan Borrello, MD, Martin Gutierrez, MD, Emma C. Scott, MD, Deepika Cattry, MSc, CCRP, Bjoern Chapuy, MD PhD, Azra H. Ligon, PhD, Scott J. Rodig, MD PhD, Lili Zhu, MSc, Joseph F. Grosso, PhD, Su Young Kim, MD PhD, Margaret A. Shipp, MD

Blood (2014) 124 (21): 289.

https://doi.org/10.1182/blood.V124.21.289.289

Published: 2014

Journal Articles

Novel Focal Gene Deletions in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia Detected By Array Comparative Genomic Hybridization

Ingegerd Ivanov Öfverholm, MD, Anh Nhi Tran, PhD, Vasilios Zachariadis, MD, Mats Heyman, MD PhD, Eva Rudd, MD PhD, Elisabeth Syk Lundberg, MD PhD, Magnus Nordenskjöld, MD, PhD, Ann Nordgren, MD PhD, Gisela Barbany, MD PhD

Blood (2014) 124 (21): 1085.

https://doi.org/10.1182/blood.V124.21.1085.1085

Published: 2014

Journal Articles

Passage-Dependent Cancerous Transformation Of Human Mesenchymal Stem Cell Of Adipose Origin During In Vitro Culture

Jung Ah Kim, MD, Qute Choi, MD, Kyong Ok Im, Ji Seok Kwon, Si Nae Park, Seon Young Kim, MD, Sang Mee Hwang, MD, Yeon-Mok Oh, MD, Dong Soon Lee, MD, PhD

Blood (2013) 122 (21): 4862.

https://doi.org/10.1182/blood.V122.21.4862.4862

Published: 2013

Journal Articles

The Effect of Number of Metaphases Studied and Abnormal Metaphase Percentage On Cytogenetic Risk Stratification in Primary Myelofibrosis

Shaina A Rozell, MD, Biruk Mengistu, M.D., Naseema Gangat, MD, Curtis A. Hanson, MD, Ryan A Knudson, Rhett P Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2012) 120 (21): 1742.

https://doi.org/10.1182/blood.V120.21.1742.1742

Published: 2012

Journal Articles

Trisomy of the Down Syndrome Critical Region Suppresses Precursor B-Cell Differentiation and Promotes B-Cell Transformation Associated with Altered Expression of Polycomb Repressor Complex 2 Targets

Andrew A. Lane, MD, PhD, Diederik van Bodegom, PhD, Bjoern Chapuy, MD, PhD, Gabriela Alexe, PhD, Timothy J Sullivan, PhD, Trevor Tivey, Tovah Day, PhD, John Crispino, PhD, Edward Fox, PhD, Kimberly Stegmaier, MD, David Weinstock, MD

Blood (2012) 120 (21): 115.

https://doi.org/10.1182/blood.V120.21.115.115

Published: 2012

NARROW

PD-L1 Gene Alterations Identify a Unique Subset of Diffuse Large B Cell Lymphoma That Harbors a T Cell Inflamed Phenotype

Effect of Continuous Lenalidomide Treatment on Copy Number Alteration and Cytogenetic Abnormalities in Multiple Myeloma Cells

Age-Related Chromosomal Aberrations in Patients with Diffuse Large B-Cell Lymphoma

A Lysa Phase II Study of Oral JAK1/2 Inhibitor Ruxolitinib in Advanced Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL)

Chromosome 9p24.1/ PD-L1 / PD-L2 Alterations and PD-L1 Expression and Treatment Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Nivolumab (PD-1 Blockade)

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Concurrent BCL2 / MYC Gene Amplification Associates with Increased DNA G-Quadruplex Formation in DLBCL

Nivolumab in Patients with Relapsed or Refractory Hodgkin Lymphoma - Preliminary Safety, Efficacy and Biomarker Results of a Phase I Study

Novel Focal Gene Deletions in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia Detected By Array Comparative Genomic Hybridization

Passage-Dependent Cancerous Transformation Of Human Mesenchymal Stem Cell Of Adipose Origin During In Vitro Culture

The Effect of Number of Metaphases Studied and Abnormal Metaphase Percentage On Cytogenetic Risk Stratification in Primary Myelofibrosis

Trisomy of the Down Syndrome Critical Region Suppresses Precursor B-Cell Differentiation and Promotes B-Cell Transformation Associated with Altered Expression of Polycomb Repressor Complex 2 Targets

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only